BeStock  
Stocks › Biotechnology › SLS

Sellas Life Sciences SLS

US equityMarket cap rank #2495Biotechnology
$13.66 −$1.20 (-8.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $14.21 +4.03%
Open$14.98
Prev close$14.86
Day range$13.39 – $15.19
Volume15.48M
Market cap$2.78B
P/E (TTM)–
Dividend yield–

SLS Stock News

Headlines matching Sellas Life Sciences or the SLS ticker, most recent first.

  • Sims Ltd: SLS Investor Day PresentationASX · 18 Sep 2026 · Direct mention
  • Solstice Minerals Ltd: Application for quotation of securities - SLSASX · 14 Sep 2026 · Direct mention
  • Maxim Group Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Maintains Target Price $30Market news · 20 Aug 2026 · Direct mention
  • Earnings Flash (SLS) SELLAS Life Sciences Posts Q2 Loss $0.05, Vs. FactSet Est of $0.05 Loss NegativeMT Newswires · 12 Aug 2026 · Direct mention
  • Maxim Group Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Raises Target Price to $30 PositiveMarket news · 9 Jul 2026 · Direct mention
  • A. G. P. Initiates Sellas Life Sciences(SLS.US) With Buy Rating, Announces Target Price $25Market news · 6 Jul 2026 · Direct mention
  • Pre-Market Movement | SLS.US Stock Price Fluctuates Amid Multiple News ItemsMarket news · 3 Jun 2026 · Direct mention
  • Maxim Group Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Maintains Target Price $10Market news · 15 May 2026 · Direct mention
  • A. G. P. Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Maintains Target Price $10Market news · 13 May 2026 · Direct mention
  • A. G. P. Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Raises Target Price to $10 PositiveMarket news · 20 Mar 2026 · Direct mention
  • Maxim Group Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Raises Target Price to $10 PositiveMarket news · 14 Mar 2026 · Direct mention
  • Solstice Minerals Ltd: Application for quotation of securities - SLSASX · 6 Nov 2026 · Direct mention
  • Sims Ltd: Appointment of Tiffany Osias as President of SLSASX · 5 Nov 2026 · Direct mention
  • Maxim Group Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Maintains Target Price $30Market news · 15 Nov 2026 · Direct mention
  • Divergence in Insider Trading Among U.S. Biotech Stocks: ImmunityBio (IBRX.US) Sees Largest Cash-Out, While Sellas (SLS.US) Directors Buy In Before 5-Fold Surge PositiveZhitong Finance · 12 Nov 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on SLS.

Sign in to join the discussion.

Scroll to Top